1st Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$930,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Branded prescription drug fee under the Accountable Care Act

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially benefit Eisai Inc., so to Eisai Co. Ltd, as its parent, will benefit.

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES

Financial Institutions/Investments/Securities FIN

Student Loan Auction Rate Securities

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially benefit Eisai Inc., so to Eisai Co. Ltd, as its parent, will benefit.

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE

Education EDU

Student Loan Auction Rate Securities

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially benefit Eisai Inc., so to Eisai Co. Ltd, as its parent, will benefit.

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of

Pharmacy PHA

drug shortages, supply chain integrity DEA-FDA issues Prescription Drug User Fee Act reauthorization

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially benefit Eisai Inc., so to Eisai Co. Ltd, as its parent, will benefit.

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Obesity awareness Breast cancer awareness Health disparities in medical access/treatment

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially benefit Eisai Inc., so to Eisai Co. Ltd, as its parent, will benefit.

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM Legislative Assistant, Sen. Mike Crapo

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.